Your browser doesn't support javascript.
loading
Recommended measurement instruments for genitourinary symptoms associated with menopause: the COMMA (Core outcomes in menopause) consortium.
Paramanandam, Vincent S; Lensen, Sarah; Gabes, Michaela; Kann, Gesina; Donhauser, Theresa; Waters, Niamh F; Li, Anna D; Peate, Michelle; Susanto, Nipuni S; Caughey, Lucy E; Rangoonwal, Fatema; Liu, Jingbo; Condron, Patrick; Obalowu, Ismaila Aberi; Archer, David F; Bell, Robin J; Christmas, Monica; Davies, Melanie; Davis, Susan R; Giblin, Karen; Iliodromiti, Stamatina; Jaisamrarn, Unnop; Khandelwal, Sunila; Kiesel, Ludwig; Aggarwal, Neelam; Mitchell, Caroline M; Mishra, Gita D; Nappi, Rossella E; Panay, Nick; Roberts, Helen; Rozenberg, Serge; Shifren, Jan; Simon, James A; Stute, Petra; Vincent, Amanda J; Wolfman, Wendy; Hickey, Martha.
Afiliación
  • Paramanandam VS; From the Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
  • Lensen S; Department of Obstetrics and Gynaecology, Royal Women's Hospital, University of Melbourne, Melbourne, Australia.
  • Gabes M; Institute of Social Medicine and Health Systems Research, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
  • Kann G; University Regensburg, Regensburg, Germany.
  • Donhauser T; Institute of Social Medicine and Health Systems Research, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
  • Waters NF; Department of Obstetrics and Gynaecology, Royal Women's Hospital, University of Melbourne, Melbourne, Australia.
  • Li AD; Department of Obstetrics and Gynaecology, Royal Women's Hospital, University of Melbourne, Melbourne, Australia.
  • Peate M; Department of Obstetrics and Gynaecology, Royal Women's Hospital, University of Melbourne, Melbourne, Australia.
  • Susanto NS; Department of Obstetrics and Gynaecology, Royal Women's Hospital, University of Melbourne, Melbourne, Australia.
  • Caughey LE; Department of Obstetrics and Gynaecology, Royal Women's Hospital, University of Melbourne, Melbourne, Australia.
  • Rangoonwal F; Department of Obstetrics and Gynaecology, Royal Women's Hospital, University of Melbourne, Melbourne, Australia.
  • Liu J; Department of Obstetrics and Gynaecology, Royal Women's Hospital, University of Melbourne, Melbourne, Australia.
  • Condron P; University Library, The University of Melbourne, Parkville, Australia.
  • Obalowu IA; General Hospital Ilorin, Ilorin, Kwara State, Nigeria.
  • Archer DF; Obstetrics and Gynaecology, Eastern Virginia Medical School, Norfolk, VA.
  • Bell RJ; Women's Health Research Program, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Christmas M; Department of Obstetrics and Gynaecology, University of Chicago, Chicago, IL.
  • Davies M; Institute for Women's Health, University College London, UK.
  • Davis SR; Women's Health Research Program, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Giblin K; Red Hot Mamas North America, Inc., Bridgewater, New Jersey, United States.
  • Iliodromiti S; Women's Health Research Unit, Wolfson Institute of Population Health, QMUL, London, UK.
  • Jaisamrarn U; Menopause Research Group, Department of Obstetrics and Gynaecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Khandelwal S; Department of Obstetrics and Gynaecology, Fortis Escort Hospital, Jaipur, India.
  • Kiesel L; Department of Gynaecology and Obstetrics, University of Muenster, Muenster, Germany.
  • Aggarwal N; Department of Gynaecology and Obstetrics, PostGraduate Institute of Medical Education & Research, Chandigarh, India.
  • Mitchell CM; Vincent Center for Reproductive Biology, Massachusetts General Hospital, Boston, MA.
  • Mishra GD; Australian Women and Girls' Health Research Centre, School of Public Health, University of Queensland, St Lucia, Australia.
  • Nappi RE; Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS San Matteo Foundation, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
  • Panay N; Queen Charlotte's & Chelsea and Chelsea and Westminster Hospitals, Imperial College London, London, UK.
  • Roberts H; Auckland District Health Board, Auckland, New Zealand.
  • Rozenberg S; Department of Ob-Gyn CHU St Pierre, Université Libre de Bruxelles, Brussels, Belgium.
  • Shifren J; Midlife Women's Health Center, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Simon JA; Department of Obstetrics and Gynecology, George Washington University, Washington, DC.
  • Stute P; Department of Obstetrics and Gynecology, University Clinic Inselspital, Bern, Switzerland.
  • Vincent AJ; Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Australia.
  • Wolfman W; Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Canada.
  • Hickey M; Department of Obstetrics and Gynaecology, Royal Women's Hospital, University of Melbourne, Melbourne, Australia.
Menopause ; 31(7): 591-599, 2024 Jul 01.
Article en En | MEDLINE | ID: mdl-38743907
ABSTRACT

OBJECTIVE:

The aim of the study is to identify appropriate definitions and patient-reported outcome measures (PROMs) for each of the eight core outcomes previously selected for genitourinary symptoms associated with menopause pain with sex, vulvovaginal dryness, vulvovaginal discomfort or irritation, discomfort or pain when urinating, change in most bothersome symptom, distress, bother or interference of genitourinary symptoms, satisfaction with treatment, and side effects.

METHODS:

We conducted a systematic review to identify possible definitions and PROMs, including their measurement properties. Identified definitions and relevant PROMs with acceptable measurement properties were entered into an international consensus process involving 28 participants from 10 countries to achieve final recommendations for each core outcome.

RESULTS:

A total of 87 publications reporting on 34 PROMs were identified from 21,207 publications screened. Of these 34 PROMs, 29 were not considered to sufficiently map onto the core outcomes, and 26 of these also had insufficient measurement properties. Therefore, only five PROMs corresponding to two core outcomes were considered for recommendation. We recommend the PROMIS Scale v2.0 - Sexual Function and Satisfaction Vaginal Discomfort with Sexual Activity to measure the outcome of "pain with sexual activity" and the Day-to-Day Impact of Vaginal Aging (DIVA) Questionnaire to measure "distress, bother or interference" from genitourinary symptoms. Six definitions of "side effects" were identified and considered. We recommend that all trials report adverse events in study participants, which is a requirement of Good Clinical Practice.

CONCLUSIONS:

Suitable PROMs and definitions were identified to measure three of eight core outcomes. Because of the lack of existing measures, which align with the core outcomes and have evidence of high-quality measurement properties, future work will focus on developing or validating PROMs for the remaining five core outcomes.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Menopausia / Medición de Resultados Informados por el Paciente Límite: Female / Humans / Middle aged Idioma: En Revista: Menopause Asunto de la revista: GINECOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Menopausia / Medición de Resultados Informados por el Paciente Límite: Female / Humans / Middle aged Idioma: En Revista: Menopause Asunto de la revista: GINECOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Australia